Home/Filings/4/0001641172-25-026893
4//SEC Filing

Mun-Gavin David C. 4

Accession 0001641172-25-026893

CIK 0000109657other

Filed

Sep 7, 8:00 PM ET

Accepted

Sep 8, 5:45 PM ET

Size

5.6 KB

Accession

0001641172-25-026893

Insider Transaction Report

Form 4
Period: 2025-09-04
Transactions
  • Award

    Option to purchase Common Stock

    2025-09-04+31,25031,250 total
    Exercise: $1.33Exp: 2035-08-19Common Stock (31,250 underlying)
Footnotes (1)
  • [F1]The options are fully vested and exercisable.

Documents

1 file

Issuer

GT Biopharma, Inc.

CIK 0000109657

Entity typeother

Related Parties

1
  • filerCIK 0002078965

Filing Metadata

Form type
4
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 5:45 PM ET
Size
5.6 KB